Experience of palivizumab in prophylaxis of respiratory syncytial viral infection in premature children with bronchopulmonary dysplasia

Aliamovskaia, G.A.; Keshinian, E.S.

Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 12: 30; 32-34

2012


ISSN/ISBN: 0869-6047
PMID: 23530423
Document Number: 659871
The data on prophylaxis efficacy of the Palivizumab (synagis) against respiratory syncytial viral infection in premature children with bronchopulmonary dysplasia are shown in the article. No side-effects, good tolerance and decrease of the frequency of bronchopulmonary dysplasia relapses and other viral diseases in whole in such children were registered.

Document emailed within 1 workday
Secure & encrypted payments